Evaluation of Superselective Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate in Treating Lower Gastrointestinal Bleeding: A Retrospective Study on Seven Cases

Abstract EN

Background.

To investigate the safety and efficacy of superselective transcatheter arterial embolization (TAE) with n-butyl cyanoacrylate (NBCA) in treating lower gastrointestinal bleeding caused by angiodysplasia.

Methods.

A retrospective study was performed to evaluate the clinical data of the patients with lower gastrointestinal bleeding caused by angiodysplasia.

The patients were treated with superselective TAE with NBCA between September 2013 and March 2015.

Angiography was performed after the embolization.

The clinical signs including melena, anemia, and blood transfusion treatment were evaluated.

The complications including abdominal pain and intestinal ischemia necrosis were recorded.

The patients were followed up to evaluate the efficacy in the long run.

Results.

Seven cases (2 males, 5 females; age of 69.55 ± 2.25 ) were evaluated in the study.

The embolization was successfully performed in all cases.

About 0.2–0.8 mL (mean 0.48 ± 0.19 mL) NCBA was used.

Immediate angiography after the embolization operation showed that the abnormal symptoms disappeared.

The patients were followed up for a range of 2–19 months and six patients did not reoccur.

No serious complications, such as femoral artery puncture point anomaly, vascular injury, and intestinal necrosis perforation were observed.

Conclusion.

For the patients with refractory and repeated lower gastrointestinal hemorrhage due to angiodysplasia, superselective TAE with NBCA seem to be a safe and effective alternative therapy when endoscopy examination and treatment do not work.